<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang CR</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>China Medical University, Taiwan</funding><funding>Asia University Hospital</funding><funding>National Health Research Institutes</funding><funding>National Science and Technology Council</funding><funding>China Medical University Hospital</funding><pagination>6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10777576</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Metabolic associated steatohepatitis (MASH) is metabolic disease that may progress to cirrhosis and hepatocellular carcinoma. Mouse models of diet-induced MASH, which is characterized by the high levels of fats, sugars, and cholesterol in diets, are commonly used in research. However, mouse models accurately reflecting the progression of MASH in humans remain to be established. Studies have explored the potential use of serological metabolites as biomarkers of MASH severity in relation to human MASH.&lt;h4>Methods&lt;/h4>We performed a comparative analysis of three mouse models of diet-induced MASH in terms of phenotypic and metabolomic characteristics; MASH was induced using different diets: a high-fat diet; a Western diet; and a high-fat, high-cholesterol diet. Liver cirrhos</pubmed_abstract><journal>Biomarker research</journal><pubmed_title>Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis.</pubmed_title><pmcid>PMC10777576</pmcid><funding_grant_id>NSTC 112-2320-B-039-005</funding_grant_id><funding_grant_id>MOST 110-2314-B-039-046</funding_grant_id><funding_grant_id>AUH-11151021</funding_grant_id><funding_grant_id>CMU111-MF-41</funding_grant_id><funding_grant_id>NHRI-EX112-11110BI</funding_grant_id><funding_grant_id>CMU109-MF-26</funding_grant_id><funding_grant_id>DMR-110-025</funding_grant_id><funding_grant_id>NSTC 111-2622-B-039-004</funding_grant_id><funding_grant_id>MOST 111-2314-B-039-062-MY3</funding_grant_id><funding_grant_id>MOST 111-2320-B-039-011</funding_grant_id><pubmed_authors>Yang CR</pubmed_authors><pubmed_authors>Lai HC</pubmed_authors><pubmed_authors>Hung YC</pubmed_authors><pubmed_authors>Lin WJ</pubmed_authors><pubmed_authors>Ma WL</pubmed_authors><pubmed_authors>Shen PC</pubmed_authors><pubmed_authors>Liao PY</pubmed_authors><pubmed_authors>Dai YC</pubmed_authors><pubmed_authors>Mehmood S</pubmed_authors><pubmed_authors>Cheng WC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis.</name><description>&lt;h4>Background&lt;/h4>Metabolic associated steatohepatitis (MASH) is metabolic disease that may progress to cirrhosis and hepatocellular carcinoma. Mouse models of diet-induced MASH, which is characterized by the high levels of fats, sugars, and cholesterol in diets, are commonly used in research. However, mouse models accurately reflecting the progression of MASH in humans remain to be established. Studies have explored the potential use of serological metabolites as biomarkers of MASH severity in relation to human MASH.&lt;h4>Methods&lt;/h4>We performed a comparative analysis of three mouse models of diet-induced MASH in terms of phenotypic and metabolomic characteristics; MASH was induced using different diets: a high-fat diet; a Western diet; and a high-fat, high-cholesterol diet. Liver cirrhos</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-06-03T14:56:40.137Z</modification><creation>2024-12-04T08:30:53.976Z</creation></dates><accession>S-EPMC10777576</accession><cross_references><pubmed>38195587</pubmed><doi>10.1186/s40364-023-00555-9</doi></cross_references></HashMap>